3.24
Fattori che Influenzano la Dissoluzione: Polimorfismo, Amorfismo e Pseudopolimorfismo
Il polimorfismo si riferisce all'esistenza di una sostanza farmacologica in molteplici forme cristalline, note come polimorfi. Di recente, questo term…
La dissoluzione dei farmaci è influenzata dal polimorfismo, che si riferisce all'esistenza di una sostanza farmaceutica in molteplici forme cristalline come polimorfi, solvati e forme amorfe.
I polimorfi di un farmaco condividono la stessa formula chimica ma strutture chimiche diverse, e quindi esibiscono proprietà fisiche diverse.
Ad esempio, la sospensione di cloramfenicolo ha più forme cristalline. Tuttavia, una percentuale più elevata di β-polimorfo altamente solubile migliora l'assorbimento del farmaco.
I polimorfi metastabili possono convertirsi in una forma più stabile durante la produzione e possono causare problemi come la rottura delle compresse o la prevenzione della compressione della granulazione.
Durante il processo di produzione, alcuni farmaci interagiscono con i solventi per formare solvati. Diverse forme cristalline di questi solvati sono indicate come pseudopolimorfi.
Quando il solvente è l'acqua, si formano gli idrati. Nel caso degli idrati di eritromicina, il grafico della percentuale disciolta rispetto al tempo mostra diversi modelli di solubilità per le forme diidrato, monoidrato e anidrato.
Infine, le forme amorfe mancano di strutture cristalline e si dissolvono più rapidamente in soluzioni acquose rispetto ai cristalli.
View the full transcript and gain access to JoVE Core videos
Q1: What is polymorphism and how does it affect drug dissolution?
Polymorphism refers to a drug substance existing in multiple crystalline forms with the same chemical formula but different structures and physical properties. Different polymorphs exhibit varying solubility rates; for example, chloramphenicol's highly soluble β-polymorph enhances drug absorption compared to less soluble forms. This variation directly impacts dissolution rates and bioavailability.
Q2: Why do metastable polymorphs cause problems during drug manufacturing?
Metastable polymorphs can convert to more stable forms during manufacturing, causing tablet cracking or preventing granulation compression. These transitions occur because metastable forms possess higher free energy than stable polymorphs. Such changes may require product reformulation to maintain pharmaceutical quality and efficacy.
Q3: What are solvates and pseudopolymorphs in pharmaceutical formulations?
Solvates form when drugs interact with solvents during manufacturing. When water is the solvent, specific crystalline forms called hydrates are produced. These pseudopolymorphs possess different solubility characteristics than their anhydrous counterparts; for instance, erythromycin hydrates show distinct dissolution patterns compared to the anhydrate form.
Q4: How do amorphous drug forms compare to crystalline forms in dissolution?
Amorphous forms lack crystalline structures and dissolve more rapidly in aqueous solutions than crystalline forms. Being less structurally rigid, amorphous drugs often exhibit faster dissolution rates. However, some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, potentially leading to incomplete absorption.
Q5: Why does anhydrous ampicillin absorb faster than ampicillin trihydrate?
The anhydrous form of ampicillin dissolves more quickly than ampicillin trihydrate, resulting in faster absorption. This difference stems from the distinct solubility characteristics of hydrated versus anhydrous forms. Faster dissolution of the anhydrous form enables more rapid drug availability for mechanisms of drug absorption paracellular transcellular and vesicular transport.
Q6: What determines whether a polymorph is stable or metastable?
The most stable polymorph has the lowest free energy, making it thermodynamically favored. Metastable polymorphs possess higher free energy and may spontaneously transition to more stable forms over time. This energy difference explains why certain crystal forms persist during manufacturing while others convert, potentially causing formulation problems.
Q7: How do hydrate forms of erythromycin differ in their dissolution behavior?
Erythromycin exists in dihydrate, monohydrate, and anhydrate forms, each displaying different solubility patterns. When percent dissolved is plotted against time, these hydrate forms show distinct dissolution curves. The variation in water content directly influences the crystal structure and aqueous solubility of each form.